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in childhood and adolescence. It is characterized by age-inappropriate levels of inattention,
impulsivity, and hyperactivity and is associated with long-term academic, social, and mental
health problems (1, 2). Both pharmacotherapy and behavior therapy yield short-term symptom
reduction in individuals with ADHD. Psychostimulants, in particular, have been shown to improve
attention and to decrease activity levels in children in the short term. However, their impact on
academic performance and quality of life is low (3, 4), and initial symptomatic effects are not usually
sustained on long-term follow-up (5, 6). The unproven long-term efficacy of commonly used
ADHD drugs, together with concerns in regard to adverse effects of medication, which can be as
serious as growth retardation and severe cardiovascular events (7, 8), has led to a search for
alternative treatment options.
A range of nutrients have been linked to brain development and functioning, and diet may be a
relevant factor in the high incidence and prevalence of mental disorders (9). As early as the 1920s, a
possible association between food and hyperkinetic behavior was suggested (10). Children with
ADHD and healthy controls appear to have different dietary patterns (11–13). Growing evidence
suggests that nutrients, diet, and other lifestyle factors may play a role in the pathophysiology and
management of mental disorders (14), including ADHD (15, 16).
Major dietary compounds proposed to be helpful in the treatment of ADHD include
micronutrients, such as minerals and vitamins, and polyunsaturated fatty acids (PUFAs). Several
studies have demonstrated reduced blood plasma levels of various minerals, such as magnesium,
iron, and zinc in children with ADHD at group level, and their supplementation may reduce ADHD
symptoms in individuals with respective deficiencies. However, evidence in support of this is lacking
(17). The questions of whether vitamin deficiencies are involved in the pathophysiology of ADHD
and whether vitamin supplements exert therapeutic effects also remain open (15).
The role of omega-3 PUFAs in the pathophysiology and therapy of ADHD is controversial (15,
18). Since blood levels of docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and
arachidonic acid (AA) have been found to be significantly decreased in children with ADHD
compared to controls, numerous clinical studies have examined the effects of omega-3 PUFA
supplementation on ADHD symptoms. A systematic review of meta-analyses of double-blind
placebo-controlled trials, in which ADHD symptoms were rated by parents and teachers, concluded
that the effect sizes for PUFA supplementation were small (19). The pooling of the negative results
of a more recent study with previous findings showed no overall effect of omega-3 PUFAs ong February 2020 | Volume 11 | Article 1021
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support for the efficacy of omega-3 PUFA supplementation on
the core symptoms of ADHD.
Various factors may have influenced the results of studies on
micronutrient supplementation in ADHD, e.g. heterogeneity of
design type, dosage, trial duration, or assessment of response. In
the case of PUFAs, the mode of administration (fish or
supplements), the type of PUFA employed (omega-3 or
omega-6 or combination), and the ratio between DHA, EPA,
and AA are likely to be important. An increase in the ratio
between blood levels of omega-6 to omega-3 PUFAs has been
suggested to be more significant in children with ADHD than the
absolute concentrations of either (21, 22). Focusing solely on the
supplementation of omega-3 PUFAs may not, therefore, be an
adequate treatment approach.
Whether or not individuals with low levels of certain
micronutrients are more responsive to dietary supplementation
is unknown. It is therefore important to identify subgroups of
individuals who are most likely to benefit from micronutrient
administration, including those with low baseline status. There
could also be a micronutrient threshold status, above which
dietary supplementation has little effect. Furthermore, given the
high prevalence of comorbid conditions accompanying ADHD,
it is probable that significant numbers of participants included in
the trials of supplementation of micronutrients may have had co-
occurring conditions. Observations in several ADHD studies
showed that treatment response varied depending on the
participants’ comorbidities (23).
The question of whether micronutrient administration is
effective at any time during the life span remains to be
investigated. A critical time window for positive supplementation
effects to be seen may exist; this has been demonstrated, for
example, for the lactating period in a rodent model of chronic
omega-3 PUFA deficiency (24). Developmental stage may also play
a critical role in humans, and various findings emphasize the role of
diet during pregnancy. Poormaternal diet during pregnancymay be
associated with ADHD in the offspring. Epigenetic changes evident
at birth may underlie the link between the consumption of high-fat
and high-sugar processed food and confectionary during pregnancy
and symptoms of ADHD in children with conduct problems early
in life (25). Furthermore, a prenatal diet with a high ratio of omega-
6 to omega-3 PUFAs may influence the risk of the development of
(subclinical) ADHD symptoms in the offspring during childhood
(26). In addition, maternal dietary patterns during pregnancy (low-
level healthy diet, high-level Western diet) were significantly
associated with children’s trajectories of high symptoms of
hyperactivity-inattention (27). These findings suggest that early
prevention of ADHD should specifically target diet during
pregnancy and infancy. Future studies should therefore examine
whether such interventions can prevent the occurrence of ADHD or
reduce the severity of symptoms.
The identification of a role of micronutrients and diet in
ADHD is hindered by the ill-defined nature of the disorder and
the lack of biological markers underpinning its validity (18).
Given that the biological and environmental mechanismsFrontiers in Psychiatry | www.frontiersin.org 2underlying ADHD are multifactorial, heterogeneous, and
complex (28), it is naïve to expect a simple one-fits-all solution
in regard to micronutrients, diets, or any other therapy.
The high-dosage administration of natural and seemingly
healthy micronutrients may carry the risk of unwanted side
effects. For example, vitamin E supplementation has shown a
trend towards an elevated risk of prostate carcinoma (29), while
the intake of selenium was found to elevate the risk of diabetes (30).
The supplementation of omega-3 PUFAs, particularly at supra-
physiological doses for prolonged periods of time, may also be
associated with serious adverse effects. Intervention trials with
omega-3 PUFAs have reported no serious adverse reactions at the
doses administered (31). However, since an important natural
source of omega-3 fatty acids is fish and seafood, contamination
with methylmercury, dioxins, and polychlorinated biphenyls may
increase the risk for some cancers or may harm unborn children
when consumed during pregnancy. Fish oil supplements commonly
contain antioxidants and oxidation products of omega-3 PUFAs,
both of which may lead to adverse reactions. Omega-3 fatty acids
are highly prone to oxidative degradation, and a substantial
proportion of omega-3 fish oil preparations have been found to
significantly exceed the international voluntary safety
recommendations for total oxidation (32). Animal studies have
found that oxidized lipid products, such as lipid peroxides, can
cause harm, including DNA mutations and cancer (33). The effects
of oxidized oils on human health should therefore be examined
carefully. Possible adverse consequences of the long-term use of
vitamin E added as an antioxidant to fish oil supplements should
also be considered, since large-scale trials of a-tocopherol
supplementation have suggested a link to elevated rates of
prostate cancer (34). When similar rates of adverse events are
observed in comparisons between omega-3 and placebo groups,
this applies to short-term effects only.
Recent investigations, instead of assessing the effects of single
micronutrients in children with ADHD, have examined dietary
patterns, whole diets and other lifestyle-related factors. The
findings of these studies suggest that, rather than focusing on
specific micronutrients, the entire diet should be considered. For
example, the effects of a diet commonly assumed to be healthy
(Mediterranean diet) on children and adolescents with newly
diagnosed ADHD were examined in a case–control study (35).
Low adherence to the diet was positively associated with an
increased likelihood of ADHD diagnosis. However, the study
design does not allow any conclusions in regard to cause
and effect.
Cross-sectional investigations of the effects of micronutrients
and diet usually focus on one or several compounds without
regard to other lifestyle factors, such as physical activity or
sedentary behavior. Recent studies have demonstrated the
interrelationships between diet and lifestyle in ADHD. For
example, children with ADHD were found to be almost twice
as likely to show a reduced number of healthy behaviors (36).
Moreover, primary diagnoses with ADHD were significantly
reduced in children with better quality of diet, higher levels of
physical activity and less time spent playing video games (37).February 2020 | Volume 11 | Article 102
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bidirectional communication between gut and brain (gut–brain
axis). Gutmicrobiota composition and function have recently been
associated with several mental and neurodevelopmental disorders
(38). It has been hypothesized that dysbiosis may also contribute to
the clinical phenotypes of ADHD (39, 40). For example, a slight
increase in Bifidobacterium in the gut appears to be correlated with
diminished neural reward anticipation (41), which has been found
to be associated with ADHD (42). Recent findings suggest that
broad spectrummicronutrient administrationmight be a treatment
option tomodulate Bifidobacteriumabundance,which could play a
role in the modulation and regulation of ADHD symptoms (43). A
further exploration of the role of gut microbiota and dysbiosis in
contributing to ADHD symptoms and of microbiota-related
interventions, including micronutrient supplementation and
whole diet changes, in the management of ADHD is warranted.
The role of food hypersensitivities in ADHD is a promising
avenue worthy of further exploration. A systematic review of meta-
analyses of double-blind placebo-controlled trials found no
convincing evidence of therapeutic efficacy of artificial food color
elimination, while the few-foods diet, which excludes many foods
and additives, may offer new treatment options (19). The hypothesis
of a relationship between food hypersensitivity and ADHD is
supported by several studies (44–48). A strictly supervised
restricted elimination diet has been demonstrated to be a valuable
tool in examining whether ADHD symptoms are induced by
individual foods (47). Moreover, in a randomized controlled trial,
considerable effects of this diet were observed in an unselected
group of children with ADHD (47). A recent open nonblinded pilot
study has shown a high level of compliance to an oligoantigenic diet
in children with ADHD in an out-patient setting, demonstrating its
feasibility1. The elimination of individual foods for four weeks
showed a response rate of around 60%, with statistically
significant, positive effects on attention and behavior at group
level and dramatic improvements in some children1. In addition,
children responding to the diet showed a significantly improved
quality of life1. The response rate observed by Blazynski and
colleagues1 confirms the results of previous studies (44, 46, 47).1Blazynski N, Schneider-Momm K, Overdick L, Clement C, Rauh R, Clement H-W,
et al. Oligoantigenic diet in children with ADHD. Front Psychiatry (under review).
Frontiers in Psychiatry | www.frontiersin.org 3The mechanisms underlying the effects observed on ADHD
symptoms require further investigation.
In conclusion, unhealthy dietary patterns may precede a poor
nutritional biochemistry status affecting ADHD behaviors, and the
management of nutrition and diet should always be considered as an
avenue towards improving ADHD symptoms.While several lines of
evidence point to a potential role of micronutrients and diets in
ADHD, a number of caveats need to be considered before any
therapeutic recommendation can be made. Observational studies
demonstrating associations between diet and micronutrient levels in
people withADHDand the presence or severity of symptoms do not
allowanyconclusionsoncausal relationships, since thepreference for
certain foods or dietary patterns may be a consequence of ADHD
behaviors. While a role of single micronutrients in the treatment of
ADHD at group level is not supported by current evidence,
therapeutic benefits of supplementation may depend on
pretreatment nutrient status and may be confined to individuals
with specific micronutrient deficiencies. Potential severe adverse
effects of micronutrient supplements need to be considered,
especially when administered at supra-physiological doses over
extended periods of time. Furthermore, the role of whole diets
should be explored. Generally improved lifestyle choices may
provide more substantial benefits to children with ADHD than
dietary changes alone.
The administration of an oligoantigenic diet with subsequent
reintroduction of nutrients provides amore personalized approach
to ADHD, which can reveal intolerances or allergies to foods and
allows the assessment of their impact in ADHD. The high response
rate to an oligoantigenic diet of approximately 60% found in several
studies indicates that food intolerances may be important in the
pathophysiology of ADHD. This intervention should therefore be
considered in all children with ADHD. Individuals responding
favorably to the diet should undergo an oral food challenge in order
to identify individual food intolerances. Future investigations
should use blinded designs and long-term outcome follow-up.AUTHOR CONTRIBUTIONS
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